December 23, 2021
Broader Access to Innovative Diagnostics Improves Patient Outcomes and Accelerates Clinical Trials BURLINGTON, N.C.–(BUSINESS WIRE)–Dec. 23, 2021– Labcorp (NYSE: LH), a leading global life sciences company, today announced that it … Continued
December 16, 2021
December 16, 2021 –Collaboration born out of joint commitment to bridge the gap between drug discovery and development and commercial scalability in psychiatry– –Approach expected to rapidly advance the development … Continued
November 04, 2021
NEWS PROVIDED BY Valera Health NEW YORK, Nov. 4, 2021 /PRNewswire/ — Valera Health announced today the closing of an oversubscribed $15M funding round led by Windham Venture Partners with participation from new investors Aquiline … Continued
October 14, 2021
-Advancing 11 clinical-stage assets across psychiatric conditions with Phase 2 data readouts in MDD and PTSD for each of its three lead candidates expected by mid-2023- -Over $40 million in … Continued
October 07, 2021
BALTIMORE and NEW YORK, Oct. 7, 2021 /PRNewswire/ — Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, announced the appointment of Doug Schenkel as Chief … Continued